Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02308488 · ClinicalTrials.gov registry record · NA
Study of Prone Accelerated Breast And Nodal IMRT
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 97
- Enrollment target
NCT02308488 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 97 participants.
The verdict
NCT02308488, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 97 participants
- Enrollment target
Study Summary
Following consent, patients will receive 15 fractions of radiotherapy to the affected breast and to Axillary level III and SCV (Supra-Clavicular) lymph nodes, defined by CT imaging obtained in a prone position using IMRT(intensity modulation radiation therapy ) technique: one fraction daily for 5 days/week for 3 consecutive weeks. Patients will be seen for follow-up at 45-60 days from first radiotherapy treatment, and then yearly. Patients will be assessed for Lymphedema at baseline, end of treatment, and at yearly intervals after completion of radiotherapy. All patients will be followed for toxicity and outcome (local and systemic recurrence, survival). In addition, patients will complete a self-assessment of QOL at baseline, week 3, day 45-60 and 2-yr follow-ups.
Interventions
- RADIATION Intensity-modulated radiation therapy (IMRT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2009-09 |
| Est. Completion | 2021-10-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02308488
The ClinicalTrials.gov registry entry for NCT02308488 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intensity-modulated radiation therapy (IMRT) is the first listed.
NCT02308488 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02308488 about?
NCT02308488 is a clinical study titled "Study of Prone Accelerated Breast And Nodal IMRT". Following consent, patients will receive 15 fractions of radiotherapy to the affected breast and to Axillary level III and SCV (Supra-Clavicular) lymph nodes, defined by CT imaging obtained in a prone position using IMRT(intensity modulation radiation therapy ) technique: one fraction daily for 5 da...
What is the current status of trial NCT02308488?
This trial is currently completed. It is a NA study. The enrollment target is 97 participants. The study started on 2009-09. Estimated completion is 2021-10-12.
What interventions are being tested in trial NCT02308488?
The interventions under investigation include: Intensity-modulated radiation therapy (IMRT) (RADIATION).
Who is sponsoring clinical trial NCT02308488?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.